The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing

N. Goire, G.B. Harnett, L.C. O'Reilly, Paul Ingram, Michael Leung, David Speers, P.E. Healy, Tim Inglis

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    © 2016. A local predominance of carbapenemase producing Enterobacteriaceae with low minimum inhibitory concentrations (MIC) to meropenem prompted a review of methods available for carbapenemase detection. We report on results using two selective media, temocillin discs, CarbaNP test, GeneXpert Carba-R assay and an in-house PCR assay.
    Original languageEnglish
    Pages (from-to)10-12
    JournalJournal of Microbiological Methods
    Volume124
    DOIs
    Publication statusPublished - 2016

    Fingerprint Dive into the research topics of 'The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing'. Together they form a unique fingerprint.

    Cite this